KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Net Cash Flow (2017 - 2025)

Guardant Health's Net Cash Flow history spans 9 years, with the latest figure at -$199.4 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 250.35% year-over-year to -$199.4 million; the TTM value through Dec 2025 reached -$140.8 million, up 71.96%, while the annual FY2025 figure was -$140.8 million, 71.96% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$199.4 million at Guardant Health, down from -$45.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $675.3 million in Q4 2023 and bottomed at -$356.9 million in Q2 2022.
  • The 5-year median for Net Cash Flow is -$31.6 million (2022), against an average of -$16.9 million.
  • The largest annual shift saw Net Cash Flow tumbled 614.42% in 2022 before it skyrocketed 5365.04% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$339.9 million in 2021, then soared by 94.76% to -$17.8 million in 2022, then soared by 3892.93% to $675.3 million in 2023, then plummeted by 108.43% to -$56.9 million in 2024, then crashed by 250.35% to -$199.4 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Net Cash Flow are -$199.4 million (Q4 2025), -$45.4 million (Q3 2025), and -$69.3 million (Q2 2025).